Utah Medical Products Stock Passes 200-Day Average

Shares of the medical device company reach new highs as it reports strong quarterly earnings.

Feb. 22, 2026 at 4:54pm

Got story updates? Submit your updates here. ›

Shares of Utah Medical Products, Inc. (NASDAQ:UTMD) rose above their 200-day moving average on Friday, trading as high as $68.71 per share. The medical instruments supplier reported strong quarterly earnings, with revenue of $9.04 million and earnings per share of $0.80. The company also announced a quarterly dividend of $0.31 per share.

Why it matters

Utah Medical Products is a leading designer and manufacturer of single-use medical devices, particularly in the areas of respiratory therapy and patient monitoring. The company's strong financial performance and rising stock price indicate continued demand for its innovative products in the healthcare industry.

The details

Utah Medical Products shares closed at $67.82 on Friday, with trading volume of 87,162 shares. One investment analyst has a 'sell' rating on the stock, citing a report from Weiss Ratings. However, the company reported solid quarterly results, with a net margin of 29.30% and a return on equity of 9.60%.

  • Utah Medical Products shares passed above their 200-day moving average of $59.61 on Friday, February 22, 2026.
  • The company reported quarterly earnings on Thursday, January 29, 2026.

The players

Utah Medical Products, Inc.

A designer, manufacturer and marketer of single-use medical devices focusing principally on respiratory therapy and patient monitoring applications.

Weiss Ratings

An investment research firm that has rated Utah Medical Products' stock as a 'sell (d+)'.

Got photos? Submit your photos here. ›

What they’re saying

“We must not let individuals continue to damage private property in San Francisco.”

— Robert Jenkins, San Francisco resident

The takeaway

Utah Medical Products' strong financial performance and rising stock price demonstrate the continued demand for its innovative medical devices in the healthcare industry. The company's focus on respiratory therapy and patient monitoring applications positions it well to capitalize on trends in the medical device market.